PREDICTION OF FETAL GROWTH REST IN WOMEN WITH OBESITY
- Authors: Makarova E.1, Padrul M.1, Terekhina N.A.1
-
Affiliations:
- E.A.Vagner Perm State Medical University
- Section: Methods of diagnosis and technologies
- Submitted: 20.05.2024
- Accepted: 26.08.2024
- Published: 26.08.2024
- URL: https://permmedjournal.ru/PMJ/article/view/632259
- DOI: https://doi.org/10.17816/pmj414%25p
- ID: 632259
Cite item
Full Text
Abstract
Objective. To develop a method for predicting fetal growth restriction in obese women in the first trimester of pregnancy.
Materials and methods: The study involved 85 obese pregnant women at 6-9 weeks of pregnancy. Obesity was determined by body mass index, as the ratio of height squared (m) to weight (kg), with a BMI > 30 kg/m2. For all patients, the content of total copper (Cuvol.) in the blood serum was determined using the colorimetric method, and ceruloplasmin (CP) using the method of V.S. Kamyshnikov and the percentage of free copper (Cufree) was calculated. The free copper index was calculated using the formula: Cufree = (Cuvol. – (ceruloplasmin x 3)) / Cuvol. x 100, where Cufree is the percentage of free copper in the blood serum, %; Cu ob. – content of total copper in blood serum, µmol/l; CP – content of ceruloplasmin in blood serum, mg/l; 3- conversion factor. All pregnant women were ranked into two groups depending on the percentage of free copper: group A – pregnant women with obesity and free copper content >25% (n=26); group B - obese pregnant women with a percentage of free copper <25%, (n=59). The control group consisted of 20 pregnant women with normal body weight.
Results. Among the studied groups, pregnant women with obesity showed statistically significant differences in the content of total copper (p = 0.013), and the percentage of free copper (p = 0.01). In the group of pregnant women with a free copper content of >25%, chronic placental insufficiency was 1.5 times more likely to develop and fetal growth restriction syndrome was 6.4 times more likely than in the group of patients with a free copper content of <25%.
Conclusion. The level of free copper, determined in the first trimester of pregnancy equal to or more than 25%, can serve as a predictor of fetal growth retardation in obese pregnant women.
Full Text
Introduction. With maternal obesity, fetal development and placenta formation occur under metabolically altered conditions with an imbalance of vital microelements and vitamins [1, 2]. Copper is an essential nutrient for humans. Observational studies associate elevated copper levels with the development of diseases of the cardiovascular system, liver pathology, and musculoskeletal system [3, 4, 5]. Elevated levels of free copper in the body increase oxidative stress and accelerate tissue and organ damage, contributing to the development of disease [Footnote 1].
Obese women are more likely to experience obstetric complications during pregnancy [6]. Impaired uteroplacental circulation, despite maternal overnutrition, can lead to progressive placental insufficiency (PI) and the birth of small children for their gestational age [7]. In addition, the gestational process in maternal obesity occurs against the background of changes in the rheological and coagulation properties of the blood - an increase in the overall coagulant potential, a decrease in fibrinolytic activity, which leads to disturbances in intraplacental hemodynamics and the development of pregnancy complications [6]. Placental insufficiency leads to disruption of nutritional, endocrine, immune, and gas exchange functions with the formation of fetal growth restriction syndrome (FGR) [8]. Morphological criteria for placental insufficiency are formed during the first or second wave of trphooblast invasion (6-8 and 14-16 weeks, respectively) [9], but clinical manifestations in the form of impaired blood flow in the uteroplacental bed and delayed fetal development are formed in the second half of pregnancy. Obese mothers are 2 times more likely to give birth to fetuses with fetal growth restriction, which is associated with impaired placental function and the production of insulin-like growth factor in the fetus in utero [10]. The main methods for predicting FGR are based on ultrasound measurement of fetal size during pregnancy [Footnote 2], the presence of biochemical and genetic markers [11].
Thus, fetal growth retardation remains a difficult pathology to predict and requires further work to study it, including in obese women. Purpose of the study. Development of a method for predicting fetal growth restriction in obese women in the first trimester of pregnancy. Materials and methods. The study was conducted in accordance with the ethical principles for medical research involving human subjects as outlined in the Declaration of Helsinki of the World Health Organization. 85 obese pregnant women at 6-9 weeks of pregnancy were examined at the Center for Family Planning and Prenatal Diagnostics of the Polyclinic of the Federal State Budgetary Educational Institution of Higher Education Perm State Medical University named after. Academician E.A. Wagner of the Russian Ministry of Health. Obesity was determined by body mass index, as the ratio of height squared (m) to weight (kg), with a BMI > 30 kg/m2. All pregnant women were ranked into two groups depending on the percentage of free copper: group A – pregnant women with obesity and free copper content >25% (n=26); group B - obese pregnant women with a percentage of free copper <25%, (n=59). The control group consisted of 20 pregnant women with normal body weight. For all patients, the content of total copper (Cuvol.) in the blood serum was determined by the colorimetric method [12], ceruloplasmin (CP) according to the method [13], and the percentage of free copper (Cusfree) was calculated. The calculation of the free copper index was carried out using the formula: Cufree = (Cuob. – (CPx3)) / Cuob. x 100, where Cufree is the percentage of free copper in the blood serum, %; Cuob. – content of total copper in blood serum, µmol/l; CP – content of ceruloplasmin in blood serum, mg/ml; 3- conversion factor. Descriptive statistics methods were used to analyze the results obtained; the reliability of intergroup differences was assessed using the t-test for independent samples. The difference was considered significant at a significance level of p<0.05. The relative risk was calculated using a 95% confidence interval. The construction of a prognostic model of the risk of a certain outcome was carried out using the binary logistic regression method.
Results and its discussion. The copper content in the blood serum of pregnant women with normal body weight was 33.7±2.1 µmol/l, significantly different from the copper content in the blood of women from group A (45.4±8.6 µmol/l, p=0.01 ) and group B (41.5±7.3 µmol/l, p=0.01), while no differences were found between the indicators of groups A and B, p=0.71. The content of ceruloplasmin in the blood serum of obese women from group A was lower than that of women from group B (631.4±94.6 versus 734.3±81.8 mg/l), and did not differ significantly from that of patients with normal body weight (677.4±83.4 mg/l). Using the formula, the percentage of free copper was calculated, which reflects the amount of this element not associated with proteins, mainly with ceruloplasmin. When calculating the free copper index in women with normal body weight, a value of 9.8±1.1% was revealed. The level of free copper in group A in obese pregnant women was 2.5 times higher than in pregnant women from group B (34.6±6.9% versus 14.3±7.0%, p=0.05). It has been shown that free divalent copper in excess amounts can damage cells and induce the expression of tissue procoagulant factor [14]. Such changes in the body can lead to the development of intravascular coagulation and the formation of blood clots. Severe endothelial dysfunction develops with disorders of copper metabolism during pregnancy [15].
In group A, pregnant women with a free copper content of >25% in the placental tissue are 1.5 times more likely to develop changes characteristic of chronic placental insufficiency (Table 1), while the syndrome of fetal growth retardation is 6.4 times more likely to form than in group of patients with free copper content less than 25% [OR=6.38; 95% CI 2.39-16.99 p=0.01]. In case of obesity in combination with a high content of Cufree (>25%), PN was detected in 61.5% of cases, which in 38.5% was realized in the FGR in comparison with obese women, where PN was detected in 39%, and FGR only in 6% (p=0.001) (Fig. 1). Table 1 - Relative risk of developing placental pathology (histological signs) in obese women, %.
Histological features | Group А, n=26 abs/% | Group В, n=59 abs /% | OR | 95% CI [LL-UL] | p |
Villous stromal fibrosis | 15/57,7 | 20/33,9 | 1,70 | 1,04-2,76 | 0,04 |
Thrombosis of the intervillous space | 10/38,5 | 9/15,2 | 2,52 | 1,16-5,46 | 0,01 |
Umbilical vein thrombosis | 7/26,9 | 1/1,7 | 15,88 | 1,16-122,64 | <0,001 |
Dissociation | 21/80,8 | 16/27,1 | 2,98 | 1,88-4,71 | <0,001 |
Sclerosis | 3/11,5 | 6/10,1 | 1,12 | 0,30-4,19 | 0,85 |
Obliterating angiopathy of stem supporting villi | 9/34,6 | 8/13,6 | 2,55 | 1,11-5,87 | 0,02 |
Chronic placental insufficiency (total) compensated subcompensated decompensated | 16/61,5 6/23,0 4/15,4 6/23,0 | 23/39,0 10/16,9 6/10,1 7/11,9 | 1,57 1,36 1,51 1,62 | 1,01-2,45 0,55-3,35 0,46-4,91 0,56-4,63 | 0,05 0,50 0,49 0,36 |
OR-,relative risk 95% CI [LL-UL]- confidence interval lower and upper limits |
The formation of fetal growth restriction in the presence of placental insufficiency in women with a BMI of more than 30 kg/m2 is accompanied by a significantly higher percentage of free copper (34.6±6.9% versus 14.3±7.0%, p=0.05 ).
About the authors
Elena Makarova
E.A.Vagner Perm State Medical University
Author for correspondence.
Email: makarova_803@mail.ru
ORCID iD: 0000-0002-1330-8341
SPIN-code: 4535-0467
Scopus Author ID: 278641
кандидат медицинских наук
Russian Federation, 614000, Perm, St. Petropavlovskaya, d. 26 614600, Perm, Brothers Ignatiev St., 2Michail Padrul
E.A.Vagner Perm State Medical University
Email: m-padrul@mail.ru
ORCID iD: 0000-0002-6111-5093
SPIN-code: 3347-1977
доктор медицинских наук, профессор кафедры акушерства и гинекологии №1
Russian Federation, 614000, Perm, St. Petropavlovskaya, d. 26Natalya Aleхandrovna Terekhina
E.A.Vagner Perm State Medical University
Email: terekhina@list.ru
ORCID iD: 0000-0002-0168-3785
SPIN-code: 7663-4110
Scopus Author ID: 7004162006
доктор медицинских наук, заведующая кафедрой биологической химии
Russian Federation, 614000, Perm, St. Petropavlovskaya, d. 26References
- Makarova E.L., Terekhina N.A. The effect of pregnancy on iron and copper metabolism in women with normal body weight and obese women. Clinical laboratory diagnostics. 2021; 66 (4): 205-209 (in Russian). DOI: http://dx.doi.org/10.51620/0869-2084-2021-66-4-205-209
- Kodentsova V.M., Butskaya T.V., Ladodo O.B., Risnik D.V., Makarova S.G., Olina A.A., Moshkina N.A. Taking vitamin-mineral complexes during pregnancy is necessary: a comparative analysis of current recommendations. Questions of practical pediatrics. 2022; 2(17):136-147 (in Russian).
- Song M., Vos M.B., McClain C.J. Copper-fructose interactions: A novel mechanism in the pathogenesis of NAFLD. Nutrients. 2018;10 (11):1815.
- DiNicolantonio J.J., Mangan D., O'Keefe J.H. Copper deficiency may be a leading cause of ischaemic heart disease. Open Heart. 2018; 5(2):e000784.
- Cabral M., Kuxhaus O., Eichelmann F. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study. Eur J Nutr. 2021; 60(6):3267-3278.
- Kann N.I., Sokur T.N. Features of the functional state of the fetoplacental complex in obese pregnant women // Problems of pregnancy 2004; 8: 28–34 (in Russian).
- American College of Obstetricians and Gynecologists. ACOG. Practice bulletin no 134: fetal growth restriction. Obstet Gynecol. 2013; 121(5): 1122-1133.
- Strizhakov A.N., Ignatko I.V., Timokhina E.V., Belotserkovtseva L.D. Fetal growth restriction syndrome: pathogenesis, diagnosis, treatment, obstetric tactics. M.: Publishing group GEOTAR-Media. 2014;101p. (in Russian).
- Akolekar R., Pérez Penco J.M. Fetal Diagn Ther. Am J Obstet Gynecol. 2010; 2: 27.
- Petrenko Yu.V., Ivanov D.O., Martyagina M.A. Insulin-like growth factor and its dynamics in children of the first year of life born to obese mothers. Pediatr 2019;1(10):13–20 (in Russian).
- Kan N.E., Tyutyunnik V.L., Khachatryan Z.V. Prognostic significance of determining extracellular fetal DNA in blood plasma during fetal growth retardation. Obstetrics and Gynecology 2021; 6: 60–65. (in Russian). doi: 10.18565/aig.2021.6.60-65
- Landers J.W., Zak B. Determination of serum copper and iron in a single small sample. Am J. Clin. Pathol. 1958; 29(6):590-592.
- Kamyshnikov V. S. Clinical and biochemical laboratory diagnostics: reference book. Moscow: Medpressinform 2024; 720 p. (in Russian).
- Vashchenko V.I. Ceruloplasmin from metabolite to drug. Psychopharmacology and biological narcology 2006; 6(3):1254-1269 (in Russian).
- Vukelis J. Variations of Serum Copper Values in Pregnancy. Srpski Arhiv Za Celokupno Lekarstvo 2012;140(1-2):42-46.
- Copper. (2024, April 22). Linus Pauling Institute https:// lpi.oregonstate. edu/mic/ minerals/ copper
- Clinical guidelines “Insufficient fetal growth requiring medical care for the mother,” Moscow, 2020.-P.83.
- Makarova E.L., Terekhina N.A., Padrul M.M. Patent “Method for predicting fetal growth retardation syndrome in obese pregnant women”, No. 2785904 Russian Federation. Application No. 2022125228 dated 09/26/2022. Registration date 12/14/22, publication date 12/14/22. Bulletin No. 35.-6s.
Supplementary files
![](/img/style/loading.gif)